Home / Health / Plasma Power: UK-Donated Blood Transforms Lives
Plasma Power: UK-Donated Blood Transforms Lives
15 Mar
Summary
- UK-donated plasma treatments have stabilized multiple sclerosis symptoms.
- The NHS celebrates one year of using UK-donated plasma for medicines.
- Donating plasma is encouraged to achieve UK self-sufficiency in blood products.
The NHS is marking a significant milestone, one year since patients began receiving life-saving medicines derived from UK-donated plasma. Previously reliant on imports for over two decades due to safety concerns, the ban on using UK-donated plasma for immunoglobulin medicines was lifted in February 2021. Niall Whatney, a London resident living with multiple sclerosis since 2011, shared how this plasma-derived treatment at King's College Hospital has stabilized his condition, significantly improving his quality of life and independence.
Whatney's journey highlights the transformative power of these therapies. Having previously endured frequent injections, he now receives monthly intravenous immunoglobulin (IVIG) infusions, a treatment made from donated blood plasma. This has reduced his hospital visits and prevented his symptoms from worsening. This progress is crucial as the UK still imports the majority of its plasma medicines, meeting only 23% of its demand for immunoglobulins.
The push is now towards greater self-sufficiency. The NHS is actively encouraging more plasma donations to build domestic supply. Plasma, carrying essential antibodies called immunoglobulins, is vital for individuals with rare autoimmune disorders and genetic conditions. Donna Cullen, a deputy chief nurse, emphasized the profound impact an hour of donation can have, supporting approximately 17,000 patients in the UK who depend on these plasma-derived medicines.
